Insider Trading activities of Dendreon Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dendreon Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dendreon Corp since year 2005. Table 2 shows the detailed insider transactions of Dendreon Corp since 2005. The reporting company's ticker symbol is DNDNQ. The reporting company's CIK number is 1107332.
The total value of stock buying since 2005 is $692,358.
The total value of stock sales since 2005 is $123,054,956.
The total value of stock option exercises since 2005 is $18,081,840.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Dendreon Corp (DNDNQ).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-02 0 $0 359,462 $30,816 0 $0
2013-12 0 $0 8,207 $24,144 0 $0
2012-08 10,000 $43,800 0 $0 0 $0
2012-04 0 $0 2,687 $28,388 0 $0
2012-01 0 $0 3,230 $42,752 0 $0
2011-11 32,530 $216,689 7,500 $54,000 1,248 $6,115
2011-10 0 $0 11,595 $114,017 0 $0
2011-09 20,000 $220,960 0 $0 0 $0
2011-08 0 $0 0 $0 23,397 $117,263
2011-07 0 $0 30,592 $1,181,088 3,881 $19,016
2011-06 0 $0 24,000 $942,067 9,781 $50,816
2011-05 0 $0 123,941 $4,934,595 33,219 $295,179
2011-04 0 $0 43,774 $1,796,726 19,000 $93,100
2011-03 0 $0 156,716 $5,345,177 38,000 $179,987
2011-01 0 $0 5,105 $184,364 0 $0
2010-12 0 $0 12,352 $465,375 0 $0
2010-11 0 $0 27,000 $1,021,761 0 $0
2010-10 0 $0 2,855 $107,564 0 $0
2010-09 0 $0 63,197 $2,616,362 7,948 $37,190
2010-08 0 $0 66,521 $2,553,972 7,500 $199,800
2010-07 0 $0 0 $0 86,659 $437,265
2010-06 0 $0 16,250 $634,595 56,630 $271,025
2010-05 0 $0 69,633 $3,457,791 156,478 $1,145,964
2010-04 0 $0 1,071,390 $56,896,549 542,177 $4,772,502
2010-03 0 $0 4,876 $175,536 4,876 $22,478
2010-02 0 $0 1,320 $42,240 1,320 $5,893
2009-12 0 $0 0 $0 5,215 $23,571
2009-09 0 $0 4,750 $133,000 4,750 $20,947
2009-06 0 $0 7,181 $172,344 7,181 $32,063
2009-05 0 $0 347,967 $7,420,664 347,967 $2,771,156
2009-04 0 $0 1,168,812 $28,282,247 982,880 $6,527,667
2007-10 0 $0 14,100 $105,989 0 $0
2007-04 0 $0 300,040 $4,290,833 224,107 $1,052,843
2006-06 15,000 $60,355 0 $0 0 $0
2005-04 1,000 $4,585 0 $0 0 $0
2005-03 25,800 $145,969 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Dendreon Corp insiders (DNDNQ)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-02-19 Brophy Karen (VP, Human Resources) Sale 6,132 .07 435
2015-02-18 Pacheco Silvio (SVP, Sales and Marketing) Sale 3,222 .07 222
2015-02-17 Pacheco Silvio (SVP, Sales and Marketing) Sale 2,500 .08 202
2015-02-17 Crotty Robert (EVP, General Counsel) Sale 21,764 .08 1,762
2015-02-17 Monteith William (EVP, Technical Operations) Sale 96,690 .08 7,348
2015-02-13 Sandler Andrew Seth (EVP, Chief Medical Officer) Sale 113,716 .09 10,234
2015-02-13 Monteith William (EVP, Technical Operations) Sale 1,284 .09 111
2015-02-13 Cox Greg (EVP, CFO & Treasurer) Sale 114,154 .09 10,502
2013-12-10 Rocco Lindsay (EVP, Corporate Communications) Sale 8,207 2.94 24,144
2012-08-01 Canet Gerardo (Director) Buy 10,000 4.38 43,800
2012-04-23 Frohlich Mark W (See Remarks) Sale 2,687 10.56 28,388
2012-01-23 Frohlich Mark W (See General Remarks) Sale 3,230 13.24 42,752
2011-11-14 Frohlich Mark W (See General Remarks) Sale 7,500 7.20 54,000
2011-11-14 Frohlich Mark W (See General Remarks) Option Ex 1,248 4.90 6,115
2011-11-07 Schiffman Gregory T (CFO, SVP of Finance & Treasure) Buy 30,030 6.66 199,999
2011-11-04 Johnson John (Director) Buy 2,500 6.68 16,690
2011-10-21 Frohlich Mark W (See General Remarks) Sale 3,230 10.17 32,839
2011-10-21 Urdal David (SVP, Chief Scientific Officer) Sale 1,016 10.10 10,261
2011-10-17 Urdal David (SVP, Chief Scientific Officer) Sale 2,036 9.65 19,647
2011-10-15 Urdal David (SVP, Chief Scientific Officer) Sale 5,313 9.65 51,270
2011-09-09 Bayh Susan B (Director) Buy 20,000 11.05 220,960
2011-08-09 Urdal David (SVP, Chief Scientific Officer) Option Ex 12,035 4.66 56,022
2011-08-04 Frohlich Mark W (See General Remarks) Option Ex 11,362 5.39 61,241
2011-07-25 Gold Mitchell (President & Chief Executive Of) Sale 19,000 38.37 728,973
2011-07-25 Gold Mitchell (President & Chief Executive Of) Option Ex 3,881 4.90 19,016
2011-07-21 Frohlich Mark W (See General Remarks) Sale 3,230 39.13 126,402
2011-07-21 Urdal David (SVP, Chief Scientific Officer) Sale 1,015 38.75 39,331
2011-07-17 Urdal David (SVP, Chief Scientific Officer) Sale 2,035 38.43 78,205
2011-07-15 Urdal David (SVP, Chief Scientific Officer) Sale 5,312 39.19 208,177
2011-06-27 Gold Mitchell (President & Chief Executive Of) Sale 19,000 38.69 735,167
2011-06-27 Gold Mitchell (President & Chief Executive Of) Option Ex 3,881 4.90 19,016
2011-06-06 Frohlich Mark W (See Remarks) Option Ex 5,900 5.39 31,800
2011-06-03 Canet Gerardo (Director) Sale 5,000 41.38 206,900
2011-05-26 Ranieri Richard J (SVP, Human Resources) Sale 6,371 41.00 261,211
2011-05-25 Cox Greg (VP, Finance) Sale 20,000 40.70 814,000
2011-05-25 Cox Greg (VP, Finance) Option Ex 8,826 15.99 141,154
2011-05-25 Gold Mitchell (President & Chief Executive Of) Sale 19,000 40.00 759,943
2011-05-25 Gold Mitchell (President & Chief Executive Of) Option Ex 3,881 4.90 19,016
2011-05-23 Hamm Richard F Jr (EVP, General Counsel Secretary) Sale 51,457 39.08 2,010,991
2011-05-06 Hamm Richard F Jr (SVP, General Counsel Secretary) Sale 9,113 39.18 357,074
2011-05-06 Hamm Richard F Jr (SVP, General Counsel Secretary) Option Ex 20,512 6.58 135,009
2011-05-03 Frohlich Mark W (See Remarks) Sale 18,000 40.63 731,376
2011-04-25 Gold Mitchell (President & Chief Executive Of) Sale 19,000 40.71 773,452
2011-04-25 Gold Mitchell (President & Chief Executive Of) Option Ex 19,000 4.90 93,100
2011-04-21 Frohlich Mark W (See Remarks) Sale 3,230 40.48 130,750
2011-04-21 Urdal David (SVP, Chief Scientific Officer) Sale 1,016 41.04 41,696
2011-04-18 Urdal David (SVP, Chief Scientific Officer) Sale 2,035 41.68 84,818
2011-04-15 Urdal David (SVP, Chief Scientific Officer) Sale 14,211 41.85 594,730
2011-04-14 Frohlich Mark W (See Remarks) Sale 4,282 40.00 171,280
2011-03-29 Urdal David (SVP, Chief Scientific Officer) Sale 85,716 35.00 3,000,060
2011-03-25 Gold Mitchell (President & Chief Executive Of) Sale 19,000 33.21 630,914
2011-03-25 Gold Mitchell (President & Chief Executive Of) Option Ex 19,000 4.90 93,100
2011-03-11 Dziurzynski Bogdan (Director) Sale 33,000 32.93 1,086,690
2011-03-03 Gold Mitchell (President & Chief Executive Of) Sale 19,000 33.03 627,513
2011-03-03 Gold Mitchell (President & Chief Executive Of) Option Ex 19,000 4.57 86,887
2011-01-21 Frohlich Mark W (See Remarks) Sale 2,250 35.26 79,346
2011-01-18 Frohlich Mark W (See Remarks) Sale 2,855 36.78 105,018
2010-12-14 Canet Gerardo (Director) Sale 4,456 36.32 161,837
2010-12-03 Frohlich Mark W (see remarks) Sale 7,896 38.44 303,538
2010-11-19 Schiffman Gregory T (CFO, SVP of Finance & Treasure) Sale 27,000 37.84 1,021,761
2010-10-18 Frohlich Mark W (See Remarks) Sale 2,855 37.68 107,564
2010-09-17 Hamm Richard F Jr (SVP, General Counsel Secretary) Option Ex 787 4.90 3,856
2010-09-16 Hamm Richard F Jr (SVP, General Counsel Secretary) Sale 16,828 41.97 706,220
2010-09-16 Hamm Richard F Jr (SVP, General Counsel Secretary) Option Ex 7,161 4.66 33,334
2010-09-10 Urdal David (SVP, Chief Scientific Officer) Sale 4,000 41.61 166,440
2010-09-09 Urdal David (SVP, Chief Scientific Officer) Sale 10,000 42.55 425,500
2010-09-08 Urdal David (SVP, Chief Scientific Officer) Sale 10,000 41.18 411,850
2010-09-07 Urdal David (SVP, Chief Scientific Officer) Sale 12,369 40.53 501,352
2010-09-03 Urdal David (SVP, Chief Scientific Officer) Sale 5,000 41.00 205,000
2010-09-02 Urdal David (SVP, Chief Scientific Officer) Sale 5,000 40.00 200,000
2010-08-30 Urdal David (SVP, Chief Scientific Officer) Sale 7,369 36.45 268,585
2010-08-25 Urdal David (SVP, Chief Scientific Officer) Sale 7,369 35.93 264,782
2010-08-20 Clark Ian T (Board of Director) Sale 7,500 37.46 280,965
2010-08-20 Clark Ian T (Board of Director) Option Ex 7,500 26.64 199,800
2010-08-04 Frohlich Mark W (See Remarks) Sale 4,283 40.00 171,320
2010-08-04 Urdal David (SVP, Chief Scientific Officer) Sale 40,000 39.21 1,568,320
2010-07-06 Hamm Richard F Jr (SVP, General Counsel Secretary) Option Ex 45,951 5.18 237,796
2010-07-01 Schiffman Gregory T (CFO, SVP of Finance & Treasure) Option Ex 40,708 4.90 199,469
2010-06-14 Dziurzynski Bogdan (Director) Sale 16,250 39.05 634,595
2010-06-10 Frohlich Mark W (See Remarks) Option Ex 28,377 5.20 147,560
2010-06-08 Hamm Richard F Jr (SVP, General Counsel Secretary) Option Ex 28,253 4.37 123,465
2010-05-26 Canet Gerardo (Director) Sale 4,000 43.54 174,176
2010-05-24 Dziurzynski Bogdan (Board of Director) Sale 30,000 44.34 1,330,200
2010-05-24 Dziurzynski Bogdan (Board of Director) Option Ex 30,000 8.97 269,190
2010-05-21 Urdal David (SVP, Chief Scientific Officer) Option Ex 118,049 7.04 831,064
2010-05-05 Brewer Richard B (Board of Director) Sale 4,000 53.16 212,640
2010-05-03 Cox Greg (VP of Accounting) Sale 22,889 55.19 1,263,266
2010-05-03 Cox Greg (VP of Accounting) Option Ex 8,429 5.42 45,710
2010-05-03 Clark Ian T (Board of Director) Sale 8,744 54.61 477,509
2010-04-30 Frohlich Mark W (See Remarks) Sale 43,599 54.44 2,373,529
2010-04-30 Gold Mitchell (President & CEO) Sale 154,887 54.71 8,473,712
2010-04-30 Urdal David (SVP, Chief Scientific Officer) Sale 40,000 53.93 2,157,360
2010-04-30 Schiffman Gregory T (CFO, SVP of Finance & Treasure) Sale 54,125 56.20 3,041,987
2010-04-30 Hamm Richard F Jr (SVP, General Counsel Secretary) Sale 183,960 56.04 10,173,327
2010-04-30 Hamm Richard F Jr (SVP, General Counsel Secretary) Option Ex 85,733 7.11 609,904
2010-04-30 Watson Douglas G (Board of Director) Sale 36,171 56.56 2,046,012
2010-04-30 Watson Douglas G (Board of Director) Option Ex 36,171 15.77 570,416
2010-04-29 Gold Mitchell (President & CEO) Sale 400,000 51.01 20,405,200
2010-04-29 Gold Mitchell (President & CEO) Option Ex 270,625 6.68 1,806,692
2010-04-29 Hamm Richard F Jr (SVP, General Counsel Secretary) Sale 90,000 51.03 4,592,610
2010-04-29 Hamm Richard F Jr (SVP, General Counsel Secretary) Option Ex 90,000 12.12 1,090,800
2010-04-29 Bayh Susan B (Board of Director) Sale 56,550 53.00 2,997,206
2010-04-29 Bayh Susan B (Board of Director) Option Ex 56,550 12.03 680,409
2010-04-06 Frohlich Mark W (SVP,CA & MO) Sale 3,098 40.00 123,920
2010-04-06 Frohlich Mark W (SVP,CA & MO) Option Ex 3,098 4.61 14,281
2010-03-09 Frohlich Mark W (SVP,CA & MO) Sale 4,876 36.00 175,536
2010-03-09 Frohlich Mark W (SVP,CA & MO) Option Ex 4,876 4.61 22,478
2010-02-16 Frohlich Mark W (SVP,CA & MO) Sale 1,320 32.00 42,240
2010-02-16 Frohlich Mark W (SVP,CA & MO) Option Ex 1,320 4.46 5,893
2009-12-01 Frohlich Mark W (SVP,CA & MO) Option Ex 5,215 4.52 23,571
2009-09-17 Frohlich Mark W (SVP,CA & MO) Sale 4,750 28.00 133,000
2009-09-17 Frohlich Mark W (SVP,CA & MO) Option Ex 4,750 4.41 20,947
2009-06-02 Frohlich Mark W (SVP,CA & MO) Sale 7,181 24.00 172,344
2009-06-02 Frohlich Mark W (SVP,CA & MO) Option Ex 7,181 4.46 32,063
2009-05-04 Dziurzynski Bogdan (Director) Sale 22,500 21.93 493,425
2009-05-04 Dziurzynski Bogdan (Director) Option Ex 22,500 9.90 222,750
2009-05-04 Urdal David (SVP, Chief Scientific Officer) Sale 325,467 21.28 6,927,239
2009-05-04 Urdal David (SVP, Chief Scientific Officer) Option Ex 325,467 7.83 2,548,406
2009-04-30 Frohlich Mark W (SVP,CA & MO) Sale 9,482 22.00 208,604
2009-04-30 Frohlich Mark W (SVP,CA & MO) Option Ex 9,482 4.90 46,461
2009-04-29 Cox Greg (Principal Accounting Officer) Sale 20,536 26.82 550,775
2009-04-29 Cox Greg (Principal Accounting Officer) Option Ex 8,794 5.42 47,689
2009-04-29 Gold Mitchell (President & CEO) Sale 600,000 24.92 14,952,000
2009-04-29 Gold Mitchell (President & CEO) Option Ex 542,928 6.22 3,374,840
2009-04-29 Schiffman Gregory T (Sr. VP, CFO & Treasurer) Sale 90,000 23.26 2,093,490
2009-04-29 Hamm Richard F Jr (SVP, General Counsel Secretary) Sale 20,000 24.03 480,580
2009-04-29 Ingle M Blake (Director) Sale 98,571 24.17 2,382,165
2009-04-29 Ingle M Blake (Director) Option Ex 93,621 6.55 613,311
2009-04-29 Brewer Richard B (Director) Sale 104,171 25.04 2,608,858
2009-04-29 Brewer Richard B (Director) Option Ex 104,171 7.99 832,013
2009-04-29 Watson Douglas G (Director) Sale 99,400 23.34 2,319,896
2009-04-29 Watson Douglas G (Director) Option Ex 99,400 6.78 673,633
2009-04-20 Cox Greg (Principal Accounting Officer) Sale 17,481 20.00 349,620
2009-04-20 Cox Greg (Principal Accounting Officer) Option Ex 15,313 9.07 138,842
2009-04-14 Canet Gerardo (Director) Sale 109,171 21.40 2,336,259
2009-04-14 Canet Gerardo (Director) Option Ex 109,171 7.34 800,878
2007-10-22 Canet Gerardo (Director) Sale 14,100 7.52 105,989
2007-04-10 Kunath Ruth (Director) Sale 15,000 22.16 332,325
2007-04-10 Kunath Ruth (Director) Option Ex 15,000 4.41 66,150
2007-04-05 Kunath Ruth (Director) Sale 3,950 15.10 59,645
2007-04-05 Kunath Ruth (Director) Option Ex 3,950 1.82 7,189
2007-04-04 Kunath Ruth (Director) Sale 54,000 14.87 803,034
2007-04-04 Kunath Ruth (Director) Option Ex 54,000 6.79 366,714
2007-04-03 Dziurzynski Bogdan (Director) Sale 25,000 15.04 375,900
2007-04-02 Gold Mitchell (President & CEO) Sale 202,090 13.46 2,719,929
2007-04-02 Gold Mitchell (President & CEO) Option Ex 151,157 4.05 612,790
2006-06-08 Urdal David (SVP, Chief Scientific Officer) Buy 5,000 4.04 20,200
2006-06-08 Hamm Richard F Jr (SVP, Gen. Counsel Secretary) Buy 5,000 3.99 19,950
2006-06-08 Watson Douglas G (Director) Buy 5,000 4.04 20,205
2005-04-22 Bayh Susan B (Director) Buy 1,000 4.58 4,585
2005-03-21 Watson Douglas G (Director) Buy 5,000 5.86 29,300
2005-03-18 Dziurzynskio Bogdan (Director) Buy 4,000 5.63 22,520
2005-03-18 Gold Mitchell (CEO) Buy 4,000 5.64 22,540
2005-03-18 Brewer Richard B (Director) Buy 4,400 5.61 24,684
2005-03-17 Urdal David (Chief Scientific Officer) Buy 4,400 5.58 24,565
2005-03-17 Hamm Richard F Jr (Secy.) Buy 4,000 5.59 22,360

Insider trading activities including stock purchases, stock sales, and option exercises of DNDNQ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dendreon Corp (symbol DNDNQ, CIK number 1107332) see the Securities and Exchange Commission (SEC) website.